Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2016-A01534-47 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to show that auriculotherapy decreases the number of days with painful episodes of migraine and headache after 3 months of treatment
Prospective, multicenter, controlled and randomized study.
At the inclusion:
Patients are randomized in 2 groups (distribution 2/3 AUR+, 1/3 AUR-):
After 3 months, a visit of Algology is carried out :
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| AUR+: Auriculotherapy | Experimental | Patients benefit from 3 sessions of auriculotherapy at one month intervals. |
|
| AUR-: No auriculotherapy | No Intervention | Patients do not benefit from auriculotherapy. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Auriculotherapy | Procedure | 3 sessions of auriculotherapy at one month intervals. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of days with migraine and non-migraine headache post inclusion. | Evaluated with the patient's migraine/headache/treatment diary of the last 3 months after inclusion. One day with painful episodes of migraines and non-migraines headaches is a day when:
| 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of days with migraine post inclusion. | Evaluated with the patient's migraine/headache/treatment diay of the last 3 months after inclusion. One day with painful episodes of migraines is a day when:
| 3 months |
Not provided
Inclusion Criteria:
Non inclusion Criteria:
Exclusion criteria
Woman
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mireille Michel-Cherqui, MD | Hopital Foch | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cabinet Médical | Maisons-Alfort | 94700 | France | |||
| Centre Médical de L'Olivier |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37284181 | Derived | Michel-Cherqui M, Ma S, d'Ussel M, Ebbo D, Spassova A, Chaix-Couturier C, Szekely B, Fischler M, Lemaire N, Le Guen M. Auriculotherapy in prevention of migraine attacks: an open randomized trial. Front Neurol. 2023 May 22;14:1193752. doi: 10.3389/fneur.2023.1193752. eCollection 2023. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D055097 | Auriculotherapy |
| ID | Term |
|---|---|
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Number of days with non migraine headache post inclusion. |
Evaluated with the patient's migraine/headache/treatment diary of the last 3 months after inclusion. One day with painful episodes of non-migraines headaches is a day when:
|
| 3 months |
| Intensity of pain episodes (migraines and non-migraine headaches) post inclusion: numerical scale | The intensity of the pain episodes is evaluated by the patient on a numerical scale of 1 to 3 (1 = low, 2 = moderate, 3 = intense) which is in the patient's migraine/headache/treatment diary of the 3 months after inclusion. The outcome is evaluated by the calculation of the sum of the pain intensities of migraines and non-migraine headaches . | 3 months |
| Evolution of antalgic use (triptan and non-triptan) in migraine patients. | Evaluated with the patient's migraine/headache/treatment diary of the last 3 months after inclusion. The sum of antalgic use (triptan and non-triptan):
| 3 months |
| Evaluation of the quality of life of the patient: MIDAS score | Calculation of the MIDAS score during the inclusion visit and 3 months after the inclusion visit. | 3 months |
| Tolerance of auriculotherapy treatment | The presence or absence of adverse events attributed to the treatment of auriculotherapy by the patient. | 3 months |
| Montigny-le-Bretonneux |
| 78180 |
| France |
| GHP Saint Joseph | Paris | 75014 | France |
| Hopital Foch | Suresnes | 92150 | France |
| D009422 | Nervous System Diseases |